August 6, 2019 Body mass index influences the salutary effects of Metformin on survival after lobectomy for stage I NSCLC Read more »
December 1, 2020 PD-L1 by RNA next generation sequencing: Comparison with PD-L1 IHC 22C3 and association with survival benefit from pembrolizumab with or without chemotherapy in non-small cell lung cancer Read more »
June 1, 2020 Molecular characterization of advanced muscle invasive bladder cancer (MIBC): Comparison of low-input targeted RNA sequencing (RNAseq) strategies Read more »
November 1, 2019 Unique tumor immune microenvironments of potentially PD-L1/TGF-β trap responsive tumors Read more »
August 1, 2019 Cell proliferation as a biomarker for response to immune checkpoint inhibitors in PD-L1 negative renal cell carcinoma Read more »
November 1, 2019 Haplotype analysis of the T-cell receptor beta (TCRB) locus by Long-amplicon TCRB repertoire sequencing Read more »
June 1, 2017 Tumor Mutational Burden (TMB): Assessment of inter-and intra-tumor heterogeneity Read more »
July 31, 2020 Economic burden of checkpoint inhibitor immunotherapy for the treatment of non-small cell lung cancer in U.S. clinical practice Read more »
June 20, 2020 Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer Read more »
September 1, 2021 Diverse RNA expression patterns of T cell priming markers in various solid tumors and their clinical implication Read more »